In this study, we found that the expression level of SLPI promoter-controlled GFP in HEP-2 is much higher than that in normal fibroblast 72 h after Ad-GFP infection, which might be due to differential infection or transcription, this further confirmed the tumor-specificity of this adenoviral gene therapy strategy. The gene discussed is SLPI; the disease is infection.